Premier providers of eye surgery and LASIK in Mid-Michigan and Northwest Ohio
This year more than ever, a teacher's job can be difficult, especially when glasses or contacts get in the way. That’s why we would like to show our support for our local teachers and make their jobs and lives a little bit easier.
Teachers can take advantage of $500* OFF LASIK! Schedule your FREE LASIK Consultation by filling out the form below.
*$500 off discount ($250 off per eye) is applicable towards bilateral LASIK or PRK. Cannot be combined with other offers or insurance.
Specialty Eye Institute is pleased to welcome Deborah Wu, M.D. to the practice. As a Comprehensive Ophthalmologist and Oculoplastic Specialist, Dr. Wu will be performing the following services: cataract surgery, intravitreal injections, glaucoma procedures, medical and cosmetic eye lid procedures as well as medical and cosmetic Botox. Dr. Wu is accepting new patients at the Battle Creek and Kalamazoo locations and will be doing surgery locally in Kalamazoo.
“I am delighted to welcome Dr. Wu to Specialty Eye Institute. Her diverse skillset across plastics, cataract surgery, medical retina and glaucoma is only exceeded by her emphasis on high quality patient care,” says Jonathan Jean-Pierre, CEO of Specialty Eye Institute, “The addition of Dr. Wu strengthens SEI’s commitment to patients in Kalamazoo, Battle Creek and the surrounding areas.”
Dr. Wu was born and raised in Wisconsin, she enjoys spending time with her two boys, figure skating, hiking, and traveling. She is a graduate of the University of Wisconsin and completed her residency at William Beaumont Hospital in Royal Oak, Michigan followed by a Fellowship in Oculoplastics at Consultants in Ophthalmic and Facial Plastic Surgery in Southfield, Michigan.
“After spending a decade practicing up north, I am excited to be joining the inspiring physicians and excellent staff at Specialty Eye Institute. I feel that my passion for ophthalmology and goal to take excellent care of patients, while providing an outstanding eye care experience, aligns with SEI’s vision. I enjoy educating my patients and try to treat them as if they were my own family members. I believe the patient-physician relationship is a special bond – built on respect, trust and open communication. It’s important to me to be part of a group that has the same philosophy in working together to provide the best care possible. I look forward to partnering with the physicians and patients in this community,” states Dr. Wu.
Specialty Eye Institute is pleased to welcome Alexander Cherry, M.D. to the practice. Dr. Cherry is a Glaucoma and Cataract Specialist who is accepting new patients at the Adrian, Bryan and Toledo locations.
“SEI is very fortunate to add Dr. Cherry to our practice. As a fellowship trained glaucoma ophthalmologist, he is a highly skilled surgeon who will provide our patients, the greater Toledo area, and our referring doctors state-of-the-art care as a glaucoma and cataract surgeon,” says Dr. David Bejot, Clinical Optometric Director at Specialty Eye Institute.
Dr. Cherry grew up in the Toledo area and is a diehard Buckeyes fan. He graduated from Ohio State University College of Medicine and completed his residency and Glaucoma Fellowship at the University of Kentucky.
“I am very excited to be bringing expanded access to glaucoma services to the practice. It feels like a long time in the making to return to the Toledo area to practice and I cannot wait to get started,” states Dr. Cherry.
The National Association of Business Resources (NABR) has named Specialty Eye Institute (SEI) as one of West Mic
higan’s Best and Brightest Companies to work for the second consecutive year in a row. SEI was recognized for demonstrating exceptional innovative human resource practices.
An independent research firm evaluates companies based on compensation, benefits and employee solutions; employee enrichment, engagement and retention; employee education and development; recruitment, selection and orientation; employee achievement and recognition; communication and shared vision; diversity and inclusion; work-life balance; community initiatives; and strategic company performance.
“As we move into a new chapter after COVID-19 and discover more about the “new normal” we look forward to continuing to be inspired by our employees and what they can handle to support the well-being of our patients and each other. Receiving this award, is another example of how proud I am to be working alongside such remarkable talent,” says Kathleen Fox, PHR, Director of Human Resources at Specialty Eye Institute.
The Best and Brightest Companies to Work For® is a program that identifies and honors organizations that display a commitment to excellence in operations and employee enrichment that lead to increased productivity and financial performance. This national program celebrates those companies that are making better business, creating richer lives and building a stronger community as a whole.
Interested in a career with Specialty Eye Institute, visit our career page.
JACKSON, Mich. – June 11, 2020 – Specialty Eye Institute announces that it is now offering the first and only cross-linking treatment approved by the U.S. Food and Drug Administration (FDA) for progressive keratoconus and corneal ectasia following refractive surgery, two progressive and sight-threatening eye conditions that affect more than 160,000 Americans. Specialty Eye Institute is proud to bring this exciting technology and treatment option to their patients here in Michigan.
Keratoconus is a corneal disease that creates a thinning of the cornea or the clear front surface of the eye. Normal outward pressure within the eye causes the cornea to progressively bulge into a cone-like shape that produces optical irregularities that affect vision. A rare condition, keratoconus typically appears in individuals who are in their late teens or early twenties. Early symptoms include blurring or distortion of vision or increased sensitivity to light. Corneal ectasia, also marked by progressive corneal steepening and thinning, is a rare but serious complication resulting from vision correction procedures—such as laser-assisted in-situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) and is associated with worsening vision.
Many patients in the past with keratoconus had to undergo a cornea transplant if the disease continued to progress. Corneal cross-linking is effective in halting the progression of keratoconus and corneal ectasia.
“Corneal cross-linking is the only proven way to stabilize keratoconus and we are thrilled to be able to offer this procedure for our patients,” states Kevin Lavery, M.D., Cataract & Refractive Specialist at Specialty Eye Institute.
Corneal cross-linking using Avedro’s Photrexa products and KXL System is a medical procedure that combines the use of ultra-violet (UV) light and riboflavin (vitamin B2) eye drops. The procedure works by creating new corneal collagen cross-links, which results in a shortening and thickening of collagen fibrils that leads to the stiffening the cornea. Cross-linking, which has been performed in Europe since 2003, is considered the standard of care around the world for keratoconus and corneal ecstasia following refractive surgery.
“The corneal cross-linking procedure using riboflavin is the first and only FDA approved therapeutic treatment for patients with progressive keratoconus and corneal ectasia following refractive surgery. This can possibly save a patient from a more invasive corneal transplant procedure and is now covered by many insurance plans,” states Luis Gago, M.D., Cataract & Refractive Specialist at Specialty Eye Institute.
